U.S. Residential REITs Stock News

NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Dave (DAVE) Stock Resets As Premium Valuation Faces Fresh Scrutiny

Dave stock closed on Thursday at US$365.26, down about 15% from the prior session, as the market reacted sharply to Q2 earnings. The headline was not weak revenue. Dave reported around US$171m in Q2 revenue and a 44% adjusted earnings before interest, tax, depreciation and amortisation margin, which is high for a consumer finance platform. The real issue for you as an investor sits on a longer horizon. Dave now trades on a P/E multiple that is well above both its industry and peer averages...
NYSE:FDXF
NYSE:FDXFTransportation

FedEx Freight (FDXF) Stock Rallies As Margin Squeeze Clouds Earnings Power

FedEx Freight Holding Company shares closed at US$146.42, up 2.4% after the latest earnings, as investors leaned into the freight story rather than flinched at the headline numbers. The real flashpoint in this report is profit pressure. Quarterly net income of US$51 million for the latest fiscal quarter compares with US$251 million in the same quarter a year earlier, and trailing net margin over the past year sits at 10.4% versus 15.5% in the prior year. That short term squeeze is exactly...
NYSE:WBI
NYSE:WBIEnergy Services

WaterBridge Infrastructure (WBI) Stock Reconsiders Growth As Earnings Stay Thin

WaterBridge Infrastructure entered this earnings release after a strong 90 day share run, then the stock slipped about 2.5% as the market cooled on the story. The headline is simple. Revenue reached about US$217.8 million in Q2 and earnings per share landed a little over US$0.09. For a stock often discussed as a high growth midstream water platform with valuation questions, the real swing factor this quarter is profitability. WaterBridge Infrastructure is now reporting positive earnings after...
NYSE:EME
NYSE:EMEConstruction

EMCOR Group (EME) Stock Could Be 39% Undervalued Despite Raised Guidance

EMCOR Group has been a strong stock over the past several years, yet current valuation checks suggest the market price may still sit below what its intrinsic value estimate implies. After a very large 5 year return, the key issue is whether today's price fairly reflects the business the company has become. Over the last 5 years, EMCOR Group has delivered a very large total return of about 5.8x, which puts extra focus on whether recent gains have already captured its fundamentals. Growing...
NasdaqGS:SNEX
NasdaqGS:SNEXCapital Markets

StoneX Group (SNEX) Stock Price Drop Challenges Powerful Earnings Momentum

StoneX Group stock just absorbed a 12% hit in a single session, yet the earnings story behind that move is far more complicated than a simple miss or disappointment. You are looking at a financial services platform that produced Q3 net income of US$127.9m and diluted earnings per share of US$1.00, alongside a trailing P/E of 15.4x that sits below the cited US market and industry averages. The market is reacting strongly to a single day of trading. The key question is whether that pullback...
NasdaqGM:BETR
NasdaqGM:BETRDiversified Financial

Better Home & Finance (BETR) Is Down 21.8% After CEO Exit And Amended Credit Karma Partnership – Has The Bull Case Changed?

In the second quarter of 2026, Better Home & Finance Holding reported a net loss of US$30.59 million, improved from a US$36.27 million loss a year earlier, and announced that long-time CEO Vishal Garg had stepped down, with board member Daniel Lewis taking over as Interim CEO. Alongside this leadership change, Better amended its broker agreement so that Intuit Credit Karma, rather than Better, will offer Credit Karma’s 140 million-strong U.S. consumer base access to Home Equity Line of...
NasdaqGM:VNDA
NasdaqGM:VNDABiotechs

Vanda Pharmaceuticals (VNDA) Stock Holds Steady As Losses Deepen

Vanda Pharmaceuticals stock barely budged after earnings, up about 0.5% to around US$5, even though the quarter underscored how hard the current build out is hitting the income statement. The headline is simple: revenue held around US$50.5m while the Q2 net loss widened to US$62.5m as spending on late stage trials and new launches weighed heavily. Investors came into this print after a tough stretch, with the stock down about 20% over the past month. The key question now is how long the...
NasdaqGS:EDIT
NasdaqGS:EDITBiotechs

Editas Medicine (EDIT) Stock Rallies On Revenue Jump But Losses Linger

Traders nudged Editas Medicine up about 5% today, which looks like a cautious, rather than euphoric, vote on a tricky set of numbers. The stock came into this report under pressure over the past month, so even a small relief move matters. The headline is margin pain meeting revenue progress. Total revenue for the quarter sat at US$11.89 million while the company still reported a loss with basic earnings per share at US$0.15 in the red. The real question now is whether this mix justifies...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Sandisk (SNDK) Stock Drops As Profit Surge Meets Valuation Doubts

Sandisk stock closed down 6.8% at US$1,258.58, capping a tough month for holders after a double digit slide over 30 days. That reaction sits awkwardly next to a quarter where revenue hit US$8.97b and non GAAP earnings per share jumped to US$39.25, both ahead of management guidance. The real focus is not today’s drop but what this earnings release suggests about the multi year arc. Sandisk has moved from losses to a full year of profit and now trades on a trailing P/E of 16.4x, while a...
OTCPK:NASB
OTCPK:NASBBanks

NASB Financial (NASB) Stock Slips As Profitability Strength Raises Valuation Questions

NASB Financial slipped about 1% today, even though the latest quarter showed the kind of earnings power many regional banks would welcome. Basic earnings per share for Q3 landed at roughly US$1.48 on revenue of about US$24.8 million, contributing to a trailing 12 month P/E of 8.4x that currently sits below the broader US banks sector and wider market. For short term traders the red screen might stand out. For longer term investors the focus is on the sustained profitability and the relatively...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Expedia (EXPE) Stock Slips As Margin Gains Meet Profit Taking

Expedia Group just served up the kind of quarter that usually earns a celebration, yet the stock slipped 4.1% to about US$306 after the report. The gap between the reaction and the results is striking. Revenue for Q2 came in at US$4.3b and adjusted EBITDA margin reached 25.9%, with management confident enough to lift full year margin expansion targets. Investors came into this print after a strong three month run in the stock. Today’s move suggests profit taking and nerves, while the earnings...
NasdaqGM:ALNT
NasdaqGM:ALNTElectrical

Allient (ALNT) Stock Price Surges As Margin Gains Reset The Story

Allient just ripped 19.3% higher in a single session, and that kind of move always raises the same question: Is this emotion or earnings talking? Coming into the print, the stock was already on a tear over the past quarter, and the valuation looked stretched on a P/E that sat well above peers. The headline this time is profit power. Quarterly basic earnings per share reached about US$0.62 on revenue of roughly US$153.8m, with trailing net income roughly doubling over the past year and net...
NasdaqGS:RELY
NasdaqGS:RELYDiversified Financial

Remitly Global (RELY) Stock Jumps On Margin Breakthrough And Profit Surge

Remitly Global stock jumped 7.7% today to US$25.93. That move came as investors reacted to a quarter that put profitability, not just growth, in the spotlight. Q2 revenue reached US$495 million while net income excluding special items came in at US$205.9 million, which is a sharp shift for a digital remittance platform that has spent years focused on scale. The main story is margin strength. Trailing net profit margin now sits at 16.9%, a significant increase from last year. The key question...
NasdaqGS:NOVT
NasdaqGS:NOVTElectronic

Novanta (NOVT) Stock Climbs On Margin Gains And Higher 2026 Outlook

Novanta stock just jumped 6.7% in a single session, and that move highlights how emotionally charged this earnings season has become. The market responded to a clear headline of double digit revenue growth in Q2 and an increase to full year guidance. Beneath the excitement, the key drivers were margins and cash. Adjusted gross margin reached 47% and adjusted earnings per share rose at a double digit rate, while free cash flow for the quarter was about US$65 million. For a high multiple...
NYSE:BFLY
NYSE:BFLYMedical Equipment

Butterfly Network (BFLY) Could Be 18% Overvalued Following Raised Guidance And Earnings Beat

Why Butterfly Network Stock Is Back on Investors’ Radar Butterfly Network (BFLY) is drawing fresh attention after raising its 2026 revenue outlook to US$119 million to US$123 million and issuing higher guidance for the third quarter following its latest earnings report. See our latest analysis for Butterfly Network. Butterfly Network’s raised guidance and stronger recent earnings sit alongside sharp share price momentum, with the stock posting a 30 day share price return of 9.5% and a 1 year...
NYSE:MTRN
NYSE:MTRNMetals and Mining

US Semiconductor Materials Stocks Gaining Attention After New Polysilicon Tariffs

With fresh US tariffs on imported polysilicon and new incentives for domestic production, the quiet world of semiconductor materials has suddenly moved to center stage. This policy shift could reshape where critical inputs for chips and solar panels are sourced, which matters for investors watching supply chains and pricing power. This article walks through 3 US semiconductor materials stocks exposed to this news and how each might fit, or might not fit, in a portfolio. The stocks highlighted...
NasdaqGM:TKNO
NasdaqGM:TKNOLife Sciences

Alpha Teknova (TKNO) Stock Climbs On Record Revenue As Breakeven Draws Closer

Alpha Teknova stock rose 16.4% to close at US$6.53, capping a strong week for investors who were already sitting on solid short term gains. The market is focusing on one key development above all else. The headline result is that Q2 delivered the highest quarterly revenue in the company’s history, with more than US$12 million in sales and a clear step down in the quarterly net loss. That combination of record revenue and a narrower loss appears to have driven today’s shift in sentiment. The...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera Biologics (ABCL) Stock Jumps As Cash Burn Fuels Pipeline Debate

AbCellera Biologics jumped 10.3% to US$6.53 today, a sharp move for a stock that came into the print with a mixed recent run, up over the past week but down over the past month. The market is reacting to one thing above all else: the company is leaning hard into a high cash burn and deeper quarterly loss to fund its antibody pipeline, backed by a reported US$567 million cash pile and more than US$675 million of available liquidity. The question now is whether that liquidity cushion really...
NasdaqGM:EOLS
NasdaqGM:EOLSPharmaceuticals

Evolus (EOLS) Stock Jumps On Margin Turn And EBITDA Momentum

Evolus stock just ripped almost 20% higher to US$7.41, and the move is all about one thing. The market is latching onto a margin and profitability turn that feels very different from the company investors watched over the past year. Q2 revenue of US$84.1m, helped by aesthetics demand across toxins and fillers, arrived alongside a third straight quarter of positive adjusted earnings before interest, taxes, depreciation and amortization. That shift in earnings quality is what traders are...
NasdaqCM:HDSN
NasdaqCM:HDSNTrade Distributors

Hudson Technologies (HDSN) Stock Revenue Growth Clashes With Margin Pressure

Hudson Technologies shares closed at US$5.66, down about 9% on the day, as investors reacted quickly to a quarter that looked softer on the surface. Q2 2026 net income came in at US$4.9m on US$78.3m of revenue, with gross margin squeezed to 26% as hydrofluorocarbon pricing stayed weak. Short term traders focused on that margin pressure and the earnings step down from last year. Longer term holders will be weighing that hit against a clean balance sheet with US$26m of cash and no debt, as well...
NasdaqGS:ASYS
NasdaqGS:ASYSSemiconductor

Amtech Systems (ASYS) Stock Slides Despite AI Led Margin Strength

Amtech Systems came into this earnings print with the stock under pressure, down about 30% over the past three months and off 16% over the past month, and the slide accelerated today with a 7% drop to US$14.95. The headline from the quarter is very different to that price action. Revenue reached US$22.4m with roughly 50% gross margins and about US$3.3m of adjusted EBITDA, supported by strong demand for thermal processing equipment tied to artificial intelligence infrastructure. Is Amtech...
NasdaqGM:EBMT
NasdaqGM:EBMTBanks

Eagle Bancorp Montana (EBMT) Stock Holds Steady As Margin Strength Draws Focus

Eagle Bancorp Montana stock barely flinched after earnings, ticking up just 1.1% to US$23.94. The headline story instead sits on the income statement. The bank posted Q2 basic earnings per share of US$0.47 on revenue of US$23.8m, which keeps profit generation in focus rather than share price moves. For a regional lender often viewed as a quiet compounder, the more notable signal comes from profitability quality. Net interest margin stood at 4.15%, and recent improvements in non performing...
NYSE:TROX
NYSE:TROXChemicals

Tronox (TROX) Stock Rebounds As Deeper Losses Cloud Cash Flow Turnaround

The market rushed back into Tronox Holdings, sending the stock up 18.8% to US$6.95, even though the headline story is still about losses, not profits. This titanium dioxide producer is often pitched as a cheap recovery play, with a P/S around 0.4x and a dividend on the table. Today's Q2 report put that thesis under the microscope. Revenue came in at US$868 million while the company reported another net loss. The gap between a bargain valuation and a balance sheet carrying ongoing losses is...
NYSE:EL
NYSE:ELPersonal Products

Defensive Consumer Staples Stocks for Higher Rates and Steadier Demand

With inflation still running above the Fed’s 2% target and some officials openly talking about more rate hikes, rate sensitive stocks can feel like a moving target. Essential consumer goods can look relatively steady when borrowing costs rise and growth stories lose their shine. This article walks through three consumer staples stocks exposed to this backdrop, and explains how the same news can create both opportunity and risk for your portfolio. The stocks below are just a sample, and the...